View : 26 Download: 0
New anticoagulants for the prevention and treatment of venous thromboembolism
- New anticoagulants for the prevention and treatment of venous thromboembolism
- Kim J.H.; Lim K.-M.; Gwak H.S.
- Ewha Authors
- 곽혜선; 임경민
- SCOPUS Author ID
- 곽혜선; 임경민
- Issue Date
- Journal Title
- Biomolecules and Therapeutics
- vol. 25, no. 5, pp. 461 - 470
- Anticoagulant; Heparin; Venous thromboembolism; Vitamin K antagonist
- SCIE; SCOPUS; KCI
- Anticoagulant drugs, like vitamin K antagonists and heparin, have been the mainstay for the treatment and prevention of venous thromboembolic disease for many years. Although effective if appropriately used, traditional anticoagulants have several limitations such as unpredictable pharmacologic and pharmacokinetic responses and various adverse effects including serious bleeding complications. New oral anticoagulants have recently emerged as an alternative because of their rapid onset/offset of action, predictable linear dose-response relationships and fewer drug interactions. However, they are still associated with problems such as bleeding, lack of reversal agents and standard laboratory monitoring. In an attempt to overcome these drawbacks, key steps of the hemostatic pathway are investigated as targets for anticoagulation. Here we reviewed the traditional and new anticoagulants with respect to their targets in the coagulation cascade, along with their therapeutic advantages and disadvantages. In addition, investigational anticoagulant drugs currently in the development stages were introduced. © 2017 The Korean Society of Applied Pharmacology.
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.